On January 27, 2025, the Federal Circuit held that the Patent Trial and Appeal Board (“PTAB”) “has jurisdiction over IPRs concerning expired patents.” See Apple Inc. v. Gesture Tech. Partners, LLC, 2025 WL 299939, *2 (Fed. Cir. Jan. 27, 2025).
Co-authored by Sheena Wang and Ellie Purnell of HGF limited, “CRISPR and Agriculture” was originally published by Food and Drink Technology on January 29, 2025. To access the article on the Food and Drink Technology website, please click here.
The Fedtrade® Podcast recently interviewed Tim Tierney, Director of Business Recruitment and International Trade at the Vermont Department of Economic Development, as part of our SelectUSA Investment Summit Spotlight series. The mission of the Vermont Department of Economic Development is
The Federal Circuit’s recent decision in Palo Alto Networks, Inc. v. Centripetal Networks, LLC, No. 2023-1636, 2024 WL 5114204 (Fed. Cir. Dec. 16, 2024) concerns an obviousness determination based on a motivation to combine. Below is a discussion of the
The Fedtrade® Podcast recently interviewed Jon Worren, VP Strategy & Enablement at the Toronto Region Board of Trade. As the Chamber of Commerce for Canada’s largest regional economy, the Toronto Region Board of Trade aims to make Toronto one of
On January 29, 2025, the Federal Circuit issued paired decisions addressing Samsung Bioepis’s (“SB”) and Formycon AG’s (“Formycon”) appeals of preliminary injunctions entered in ongoing aflibercept biosimilar litigations with Regeneron Pharmaceuticals, Inc. (“Regeneron”).[1] The Federal Circuit affirmed the district
With U.S. Patent and Trademark Office (USPTO) Director Kathi Vidal’s return to private practice in December 2024 and the future permanent Director yet to be tapped for nomination, it is a good time to reflect on one of the most
The Fedtrade® Podcast recently interviewed William (Bill) Hite, CEO and Founder of HSA Global, as part of our SelectUSA Investment Summit Spotlight series. With locations in Boston, Chicago, and Germany, HSA Global helps with the navigation of international expansion, offering
The Federal Circuit recently reversed a District of Delaware decision that invalidated claims of Novartis’s Orange Book listed patent, U.S. Patent No. 8,101,659 (the “’659 patent”), for its blockbuster drug Entresto®, a combination drug used to treat heart failure.
Following
The Fedtrade® podcast recently interviewed William (Bill) Kitay, Secretary of the American Chamber of Commerce in Canada for our SelectUSA Investment Summit spotlight series. With seven chapters located throughout Canada, AmCham Canada is a private, non-profit membership organization that promotes the
